Engineering Catalytic Pathway Selection in Bifunctional Human DNA Glycosylases

Abstract Catalytic function in enzymes is generally considered a fixed property of the protein scaffold. It is commonly modulated by small molecules or post-translational modifications that control the efficacy of the biochemical reaction and leave underlying alternative reaction pathways unaffected. Here, we demonstrate that catalytic pathway selection in human DNA glycosylases can be engineered through manipulation of active-site chemistry. Using a warhead strategy targeting Cys253 in the DNA glycosylase OGG1, we install a permanent chemical base that promotes efficient β-elimination throughout the catalytic cycle, converting OGG1 into a robustly bifunctional enzyme. Building on recent insights into proton-transfer chemistry and conformational control of AP-lyase reactions, we identify conserved catalytic states in the related glycosylase NTHL1 and show that the catalytic pathway can be rewired through rational manipulation of active-site residues. This work demonstrates how protein engineering can be used as a strategy to reprogram enzyme function in human HhH-GPD enzymes.

Authors

Institutions

Publication Details

Journal
ACS Bio & Med Chem Au
Published
2026-11-02
DOI
https://doi.org/10.1021/acsbiomedchemau.6c00171
Primary Topic
Enzyme Catalysis and Immobilization
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineering Catalytic Pathway Selection in Bifunctional Human DNA Glycosylases

Alicia del Prado, Miguel de Vega, Birthe Meineke, Alice Eddershaw et al.
1 links
ACS Bio & Med Chem Au
Enzyme Catalysis and Immobilization
article

Engineering Catalytic Pathway Selection in Bifunctional Human DNA Glycosylases

Alicia del Prado, Miguel de Vega, Birthe Meineke, Alice Eddershaw, Maurice Michel, Simon J. Elsässer, Kaixin Zhou
article en

Abstract

Abstract Catalytic function in enzymes is generally considered a fixed property of the protein scaffold. It is commonly modulated by small molecules or post-translational modifications that control the efficacy of the biochemical reaction and leave underlying alternative reaction pathways unaffected. Here, we demonstrate that catalytic pathway selection in human DNA glycosylases can be engineered through manipulation of active-site chemistry. Using a warhead strategy targeting Cys253 in the DNA glycosylase OGG1, we install a permanent chemical base that promotes efficient β-elimination throughout the catalytic cycle, converting OGG1 into a robustly bifunctional enzyme. Building on recent insights into proton-transfer chemistry and conformational control of AP-lyase reactions, we identify conserved catalytic states in the related glycosylase NTHL1 and show that the catalytic pathway can be rewired through rational manipulation of active-site residues. This work demonstrates how protein engineering can be used as a strategy to reprogram enzyme function in human HhH-GPD enzymes.

ACS Bio & Med Chem Au
Karolinska Institutet (SE), Centro de Biología Molecular Severo Ochoa (ES), Universidad Autónoma de Madrid (ES)
Åke Wiberg Stiftelse, Fundación Ramón Areces, Ministerio de Ciencia, Innovación y Universidades, Karolinska Institutet, Novo Nordisk, Magnus Bergvalls Stiftelse, O. E. och Edla Johanssons Vetenskapliga Stiftelse, Dr Åke Olssons Stiftelse för Haematologisk Forskning, Innovative Medicines Initiative, European Regional Development Fund
Openalex Percentile: Top 25%
Enzyme Catalysis and Immobilization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon